Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 64 of the 64 references it cites were found in a registry or an index.

Lipid management in the prevention of stroke: review and updated meta-analysis of statins for stroke prevention

Amarenco, Pierre, Labreuche, Julien · 2009 · The Lancet Neurology

Abstract

Despite the inconsistent or weak association between cholesterol and stroke, lowering of cholesterol concentrations with statins reduces the risk of stroke in high-risk populations and in patients with non-cardioembolic stroke or transient ischaemic attack. Statin therapy is the most important advance in stroke prevention since the introduction of aspirin and antihypertensive treatments. Meta-analysis of randomised trials of statins in combination with other preventive strategies, including 165 792 individuals, shows that each 1 mmol/L (39 mg/dL) decrease in LDL cholesterol equates to a reduction in relative risk for stroke of 21.1% (95% CI 6.3-33.5, p=0.009). In secondary prevention of non-cardioembolic stroke, intense reduction of LDL cholesterol by statins also significantly reduced the risk of recurrent stroke (relative risk 0.84, 0.71-0.99, p=0.03) and major cardiovascular events (0.80, 0.69-0.92, p=0.002). Future directions include assessment of a target LDL cholesterol concentration of less than 1.8 mmol/L (70 mg/dL), the effects of triglyceride-lowering therapy alone or in combination with statins, and the effects of treatments to raise HDL cholesterol concentrations.

Overview

Integrity signals

Registry

Crossref · 10.1016/s1474-4422(09)70058-4

Cites

64 of 64 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

1 more claim about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Citations

Cites

Show all 64 references

Research works printed but not linked: 2

  1. 2000, Results of low-dose (20 mg) pravastatin GISSI prevenzione trial in 4271 patients with recent myocardial infarction: do stopped trials contribute to overall knowledge?, Ital Heart J, 12, 810
  2. 1994, Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease, Lancet, 344, 1383

Cited by

See all 667

Metadata

Authors
Amarenco, P., & Labreuche, J.
Affiliations
Inserm (FR)
Corresponding author
Amarenco, Pierre
Venue
The Lancet Neurology
Publisher
Elsevier BV
Published
2009-05
Volume
8
Issue
5
Pages
453-463
ISSN
1474-4422 (ISSN-L)
OpenAlex
W2117641691
Cited by
660
References
64
Citations by year
2026: 16 · 2025: 33 · 2024: 32 · 2023: 38 · 2022: 31 · 2021: 38 · 2020: 45 · 2019: 38 · 2018: 24 · 2017: 41 · 2016: 41 · 2015: 29 · 2014: 47 · 2013: 51 · 2012: 46
FWCI
8.26
Type
journal article
Language
en
Open access
closed
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations
  • The Lancet Neurology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
  • Health Sciences › Medicine › Clinical Neurology › Acute Ischemic Stroke Management
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cerebrovascular and Carotid Artery Diseases
Keywords
statins, stroke prevention, LDL cholesterol lowering, non-cardioembolic stroke, transient ischemic attack, secondary stroke prevention, stroke recurrence, cardiovascular events, triglyceride-lowering therapy, HDL cholesterol, lipid control
MeSH terms
Aged, Female, Humans, Cholesterol, LDL, Male, Middle Aged, Regression Analysis, Risk Factors, Randomized Controlled Trials as Topic, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Intracranial Hemorrhages, Stroke, Secondary Prevention

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Lipid management in the prevention of stroke: review and updated meta-analysis of statins for stroke prevention. https://app.cochat.ai/papers/10.1016/s1474-4422(09)70058-4
The paper
Amarenco, P., & Labreuche, J. (2009). Lipid management in the prevention of stroke: review and updated meta-analysis of statins for stroke prevention. The Lancet Neurology. https://doi.org/10.1016/s1474-4422(09)70058-4

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.